Active Pharmaceutical Ingredients (API) Market to Witness Massive Growth by 2025 | Teva, DSM, Novartis, Roche, Johnson & Johnson, Dr. Reddy s, Pfizer

An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1536261?utm_source=Openpr&utm_medium=RV

An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.
The EMEA average price of Active Pharmaceutical Ingredients is in the decreasing trend, from 6695 /MT in 2012 to 5483 /MT in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.

The classification of Active Pharmaceutical Ingredients includes synthetic APIs, biotech APIs, and the proportion of synthetic APIs in 2017 is about 85%, and the proportion is in decreasing trend from 2012 to 2017.

Active Pharmaceutical Ingredients is widely used in CNS, Cardiovascular, Genitourinary/Hormonal Drugs, Respiratory, Rheumatology, Diabetes, Oncology and other field. The most proportion of Active Pharmaceutical Ingredients is used for cardiovascular, and the proportion in 2017 is 21%.

According to this study, over the next five years the Active Pharmaceutical Ingredients (API) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Active Pharmaceutical Ingredients (API) business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Active Pharmaceutical Ingredients (API) market by product type, application, key manufacturers and key regions and countries.

This study considers the Active Pharmaceutical Ingredients (API) value and volume generated from the sales of the following segments:

Segmentation by product type
Synthetic APIs
Biotech APIs

Segmentation by application
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others

The key manufacturers covered in this report
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy?s Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Active Pharmaceutical Ingredients (API) consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Active Pharmaceutical Ingredients (API) market by identifying its various subsegments.
Focuses on the key global Active Pharmaceutical Ingredients (API) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Active Pharmaceutical Ingredients (API) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Active Pharmaceutical Ingredients (API) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1536261?utm_source=Openpr&utm_medium=RV

Table of Contents:
Chapter 1. Methodology and Scope

1.1. Methodology

1.1.1. Initial data exploration

1.1.2. Statistical model and forecast

1.1.3. Industry insights and validation

1.1.4. Definition and forecast parameters

1.1.4.1. Definitions

1.1.4.2. Assumptions, methodology & forecast parameters

1.2. Data Sources

1.2.1. Primary

1.2.2. Secondary

Chapter 2. Executive Summary

2.1. Active Pharmaceutical Ingredients (API) industry 3600 synopses, 2013 - 2024

2.1.1. Business trends

2.1.2. Regional trends

2.1.3. Product trends

2.1.4. Application trends

Chapter 3. Active Pharmaceutical Ingredients (API) Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 - 2024

3.3. Industry ecosystem analysis

3.3.1. Component suppliers

3.3.2. Manufacturers

3.3.3. Distributors

3.3.4. Technology providers

3.3.5. End-user landscape

3.3.6. Vendor matrix

3.4. Technology and innovation landscape

3.4.1. Gas free magnetic cooling system

3.4.2. Compressor protection controls

3.4.3. Digital compressors

3.4.4. Green DX systems

3.4.5. Penetration of IoT in refrigeration technology

3.4.6. LED lights

3.5. Regulatory landscape

3.5.1. North America

3.5.2. Europe

3.5.3. Asia Pacific

3.5.4. Latin America

3.5.5. MEA

3.6. Industry impact forces

3.6.1. Growth drivers

3.6.1.1. Growing demand for meat and dairy products

3.6.1.2. Product development initiatives due to technological advancements

3.6.1.3. Increasing investments in food & beverages industries in North America

3.6.1.4. Growing demand for transportation refrigeration in Europe

3.6.1.5. Growing floriculture industry in France

3.6.1.6. Increasing demand for frozen food and vegetables in Asia Pacific

3.6.1.7. Rapid growth of retail sector and cold food chains in Asia Pacific and Latin America

3.6.1.8. Growth of e-commerce sector in India & China

3.6.1.9. Increasing focus on food safety and energy saving in Middle East

3.6.1.10. Growing focus of governments to reduce food wastage in Africa

3.6.1.11. Shift of manufacturing facilities towards India, China, and Brazil

3.6.2. Industry pitfalls & challenges

3.6.2.1. Fluctuating fuel prices

3.6.2.2. Stringent regulations for part suppliers and OEMs

3.6.2.3. Slow pace in upgradation & replacement of old commercial refrigeration systems

3.7. Growth potential analysis

3.8. Porter's analysis

3.8.1. Supplier power

3.8.2. Buyer power

3.8.3. Threat of new entrants

3.8.4. Threat of substitutes

3.8.5. Internal rivalry

3.9. Competitive landscape, 2017

Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

This release was published on openPR.